This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2011-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2023
Title: Hisashi Wakita: Pioneering Treatments in Epilepsy and Atopic Disease
Introduction
Hisashi Wakita, an innovative inventor based in Tsukuba, Japan, has made significant contributions to the field of medicinal chemistry with a focus on treating neurological and dermatological conditions. Holding two patents, Wakita is at the forefront of developing therapeutic agents that have the potential to improve the quality of life for patients suffering from epilepsy and atopic diseases.
Latest Patents
Wakita's latest patents include an **Epilepsy treatment agent**, which combines N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide with an AMPA-type glutamate receptor antagonist. This combination showcases effectiveness in treating epilepsy, highlighting his commitment to addressing pressing medical needs. Another noteworthy patent is for **4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives**. This compound effectively relieves itching caused by atopic diseases, emphasizing his versatility in tackling various health issues.
Career Highlights
Hisashi Wakita is currently associated with Eisai R&D Management Co., Ltd., a prominent player in the pharmaceutical industry. His role in the company underscores his dedication to research and development, aiming to transform innovative ideas into viable therapeutic solutions.
Collaborations
Wakita collaborates with talented colleagues, including Kazuki Miyazaki and Kazutomi Kusano. Together, they foster an environment of creativity and innovation, driving forward the research initiatives at Eisai R&D Management Co., Ltd. Their collaborative efforts contribute to advancing medical technologies and therapies.
Conclusion
Hisashi Wakita's work exemplifies the spirit of innovation and dedication to improving healthcare through research and development. With a focus on effective treatments for epilepsy and atopic conditions, his contributions are poised to make a lasting impact in the medical field, showcasing the importance of inventions in enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile